Oxford BioDynamics’ (OBD) House Stock Rating Reaffirmed at Shore Capital

Shore Capital reiterated their house stock rating on shares of Oxford BioDynamics (LON:OBD) in a research note published on Tuesday, LSE.Co.UK reports.

Oxford BioDynamics Stock Down 13.9 %

Oxford BioDynamics stock opened at GBX 6.32 ($0.08) on Tuesday. The business’s 50-day simple moving average is GBX 8.09 and its two-hundred day simple moving average is GBX 14.61. The company has a market cap of £19.71 million, a PE ratio of -90.29 and a beta of 0.46. Oxford BioDynamics has a fifty-two week low of GBX 5.32 ($0.07) and a fifty-two week high of GBX 52 ($0.66). The company has a debt-to-equity ratio of 106.34, a quick ratio of 2.80 and a current ratio of 1.79.

Oxford BioDynamics Company Profile

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.